Accumulating evidence in rodents suggests that a prolactin locally synthesized and released within the brain can act together with that taken up from the circulation to modulate neuroendocrine responses. The present study was designed to identify the regional patterns of prolactin expression in the adult and developing sheep brain. Specifically, we tested the hypothesis that prolactin is expressed in regions of the adult and fetal sheep brain that are critical in the development of neuroendocrine homeostatic and behavioral functions. The expression of prolactin protein in sheep brain was demonstrated by Western blot analysis and brain prolactin mRNA was detected and sequenced using RT-PCR. In situ hybridization histochemistry revealed that prolactin mRNA was expressed in the medial preoptic area, periventricular preoptic nucleus, bed nucleus of the stria terminalis, and in the paraventricular nucleus of the hypothalamus, particularly the ventral region. The neuroanatomical distribution of prolactin mRNA was best visualized in the fetus and prolactin-immunoreactive neurons could also be identified in late gestation fetuses. Brain prolactin mRNA was expressed as early as day 60 of gestation and increased as the fetus aged and peaked at day 135 (term = 147 days). Prolactin mRNA expression did not exhibit a sex difference in the preoptic area, but in the amygdala prolactin mRNA was significantly higher in females than in males at day 100 of gestation. We conclude that prolactin expressed in adult and fetal sheep brain could be involved in neurodevelopment and/or modulation of the neuroendocrine stress axis, although it is too early to rule out other possibilities given the diverse actions that have been attributed to prolactin.

Keywords:
Prolactin, Hypothalamus, Preoptic area, Amygdala
1.
Ben Jonathan N, Mershon JL, Allen DL, Steinmetz RW: Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996;17:639–669.
2.
Fuxe K, Hokfelt T, Eneroth P, Gustafsson JA, Skett P: Prolactin-like immunoreactivity: localization in nerve terminals of rat hypothalamus. Science 1977;196:899–900.
3.
Hansen BL, Hansen GN, Hagen C: Immunoreactive material resembling ovine prolactin in perikarya and nerve terminals of the rat hypothalamus. Cell Tissue Res 1982;226:121–131.
4.
Harlan RE, Shivers BD, Fox SR, Kaplove KA, Schachter BS, Pfaff DW: Distribution and partial characterization of immunoreactive prolactin in the rat brain. Neuroendocrinology 1989;49:7–22.
5.
Paut-Pagano L, Roky R, Valatx JL, Kitahama K, Jouvet M: Anatomical distribution of prolactin-like immunoreactivity in the rat brain. Neuroendocrinology 1993;58:682–695.
6.
Siaud P, Manzoni O, Balmefrezol M, Barbanel G, Assenmacher I, Alonso G: The organization of prolactin-like-immunoreactive neurons in the rat central nervous system: light- and electron-microscopic immunocytochemical studies. Cell Tissue Res 1989;255:107–115.
7.
DeVito WJ: Distribution of immunoreactive prolactin in the male and female rat brain: effects of hypophysectomy and intraventricular administration of colchicine. Neuroendocrinology 1988;47:284–289.
8.
DeVito WJ, Avakian C, Stone S, Ace CI: Estradiol increases prolactin synthesis and prolactin messenger ribonucleic acid in selected brain regions in the hypophysectomized female rat. Endocrinology 1992;131:2154–2160.
9.
Shivers BD, Harlan RE, Pfaff DW: A subset of neurons containing immunoreactive prolactin is a target for estrogen regulation of gene expression in rat hypothalamus. Neuroendocrinology 1989;49:23–27.
10.
Suzuki S, Handa RJ: Estrogen receptor-beta, but not estrogen receptor-alpha, is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: comparison with other neuropeptides. J Comp Neurol 2005;484:28–42.
11.
Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA: Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998;19:225–268.
12.
Bakowska JC, Morrell JI: Atlas of the neurons that express mRNA for the long form of the prolactin receptor in the forebrain of the female rat. J Comp Neurol 1997;386:161–177.
13.
Bakowska JC, Morrell JI: The distribution of mRNA for the short form of the prolactin receptor in the forebrain of the female rat. Brain Res Mol Brain Res 2003;116:50–58.
14.
Ben Jonathan N, Hnasko R: Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001;22:724–763.
15.
Phelps CJ: Pituitary hormones as neurotrophic signals: anomalous hypophysiotrophic neuron differentiation in hypopituitary dwarf mice. Proc Soc Exp Biol Med 1994;206:6–23.
16.
Phelps CJ: Postnatal regression of hypothalamic dopaminergic neurons in prolactin-deficient Snell dwarf mice. Endocrinology 2004;145:5656–5664.
17.
Shingo T, Gregg C, Enwere E, Fujikawa H, Hassam R, Geary C, Cross JC, Weiss S: Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin. Science 2003;299:117–120.
18.
Sarkar DK, Yen SS: Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator. Endocrinology 1985;116:2080–2084.
19.
Selmanoff M, Shu C, Petersen SL, Barraclough CA, Zoeller RT: Single cell levels of hypothalamic messenger ribonucleic acid encoding luteinizing hormone-releasing hormone in intact, castrated, and hyperprolactinemic male rats. Endocrinology 1991;128:459–466.
20.
Drago F, Lissandrello CO: The ‘low-dose’ concept and the paradoxical effects of prolactin on grooming and sexual behavior. Eur J Pharmacol 2000;405:131–137.
21.
Mann PE, Bridges RS: Lactogenic hormone regulation of maternal behavior. Prog Brain Res 2001;133:251–262.
22.
Grillon S, Colard C, Risold PY, Fellmann D, Griffond B: Ontogenic development of prolactin immunoreactive neurons in the rat lateral hypothalamus. Neuropeptides 1998;32:327–332.
23.
Beyer C, Kolbinger W, Froehlich U, Pilgrim C, Reisert I: Sex differences of hypothalamic prolactin cells develop independently of the presence of sex steroids. Brain Res 1992;593:253–256.
24.
Roselli CE, Stormshak F, Resko JA: Distribution of aromatase mRNA in the ram hypothalamus: an in situ hybridization study. J Neuroendocrinol 2000;12:656–664.
25.
Roselli CE, Stadelman H, Reeve R, Bishop CV, Stormshak F: The ovine sexually dimorphic nucleus of the medial preoptic area is organized prenatally by testosterone. Endocrinology 2007;148:4450–4457.
26.
Sinha YN: Structural variants of prolactin: occurrence and physiological significance. Endocr Rev 1995;16:354–369.
27.
DeVito WJ: Heterogeneity of immunoreactive prolactin in the rat brain. Biochem and Biophys Res Comm 1988;150:599–604.
28.
Torner L, Nava G, Duenas Z, Corbacho A, Mejia S, Lopez F, Cajero M, Martinez de la Escalera G, Clapp C: Changes in the expression of neurohypophyseal prolactins during the estrous cycle and after estrogen treatment. J Endocr 1999;161:423–432.
29.
Clapp C, Torner L, Gutierrez-Ospina G, Alcantara E, Lopez-Gomez FJ, Nagano M, Kelly PA, Mejia S, Morales MA, Martinez de la Escalera G: The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin. Proc Natl Acad Sci USA 1994;91:10384–10388.
30.
Wilson DM III, Emanuele NV, Jurgens JK, Kelley MR: Prolactin message in brain and pituitary of adult male rats is identical: PCR cloning and sequencing of hypothalamic prolactin cDNA from intact and hypophysectomized adult male rats. Endocrinology 1992;131:2488–2490.
31.
Mueller PL, Gluckman PD, Kaplan SL, Rudolph AM, Grumbach MM: Hormone ontogeny in the ovine fetus. V. Circulating prolactin in mid- and late gestation and in the newborn. Endocrinology 1979;105:129–134.
32.
Mejia S, Morales MA, Zetina ME, Martinez de la Escalera G, Clapp C: Immunoreactive prolactin forms colocalize with vasopressin in neurons of the hypothalamic paraventricular and supraoptic nuclei. Neuroendocrinology 1997;66:151–159.
33.
Roselli CE, Larkin K, Resko JA, Stellflug JN, Stormshak F: The volume of a sexually dimorphic nucleus in the ovine medial preoptic area/anterior hypothalamus varies with sexual partner preference. Endocrinology 2004;145:478–483.
34.
Mak GK, Enwere EK, Gregg C, Pakarainen T, Poutanen M, Huhtaniemi I, Weiss S: Male pheromone-stimulated neurogenesis in the adult female brain: possible role in mating behavior. Nat Neurosci 2007;10:1003–1011.
35.
Ben Jonathan N, Liby K, McFarland M, Zinger M: Prolactin as an autocrine/paracrine growth factor in human cancer. Trends Endocr Metab 2002;13:245–250.
36.
Freemark M, Driscoll P, Andrews J, Kelly PA, Royster M: Ontogenesis of prolactin receptor gene expression in the rat olfactory system: potential roles for lactogenic hormones in olfactory development. Endocrinology 1996;137:934–942.
37.
Royster M, Driscoll P, Kelly PA, Freemark M: The prolactin receptor in the fetal rat: cellular localization of messenger ribonucleic acid, immunoreactive protein, and ligand-binding activity and induction of expression in late gestation. Endocrinology 1995;136:3892–3900.
38.
DeVito WJ, Connors JM, Hedge GA: Immunoreactive prolactin in the rat hypothalamus: in vitro release and subcellular localization. Neuroendocrinology 1987;46:155–161.
39.
Emanuele NV, Metcalfe L, Lubandro T, Rubinstein H, Kirteins L, Lawrence AM: Subcellular distribution of hypothalamic prolactin-like immunoreactivity. Brain Res 1987;407:223–229.
40.
Ben Jonathan N, Khurana S, Hnasko R: Brain Prolactin; in Pfaff DW (ed): Hormones, Brain and Behavior. New York, Elsevier Science, 2002, pp 97–120.
41.
Torner L, Maloumby R, Nava G, Aranda J, Clapp C, Neumann ID: In vivo release and gene upregulation of brain prolactin in response to physiological stimuli. Eur J Neurosci 2004;19:1601–1608.
42.
Torner L, Neumann ID: The brain prolactin system: involvement in stress response adaptations in lactation. Stress 2002;5:249–257.
43.
Challis JRG, Matthews SG, Gibb W, Lye SJ: Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000;21:514–550.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.